Company attributes
Industry
CEO
Pitchbook URL
Number of Employees (Ranges)
51 – 2005
Email Address
info@korrobio.com4
chris@tenbridgecommunications.com4
partnering@korrobio.com4
Number of Employees
845
Full Address
One Kendall Square, Building 600-700 Suite 6-401 Cambridge, MA 021394
Investors
Founded Date
2018
Total Funding Amount (USD)
207,500,000
Latest Funding Round Date
January 5, 2022
Board of Directors
CFO
Latest Funding Type
Patents Assigned (Count)
1
COO
Country
Other attributes
Announcement URL
Company Operating Status
Active
Latest Funding Round Amount (USD)
116,000,000
Korro Bio is a biotechnology company focused on the research and development of RNA editing technology. The company's proprietary platform, OPERA (Oligonucleotide Promoted Editing of RNA), is designed to use the natural base editing system of the body, specifically ADAR (Adenosine Deaminase Acting on RNA), in order to make precise, single-base edits to RNA.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
